Free Trial

Jacobs Levy Equity Management Inc. Increases Stake in MetLife, Inc. $MET

MetLife logo with Finance background

Key Points

  • Jacobs Levy Equity Management Inc. increased its stake in MetLife by 3.7%, owning a total of 958,867 shares worth approximately $76.99 million following the purchase of 33,994 additional shares.
  • MetLife reported Q2 earnings of $2.02 EPS, missing estimates of $2.32, with revenue of $17.34 billion, below expectations of $18.58 billion.
  • The company announced a quarterly dividend of $0.5675 per share, yielding 2.8%, payable on September 9th to shareholders of record on August 5th.
  • Interested in MetLife? Here are five stocks we like better.

Jacobs Levy Equity Management Inc. boosted its position in MetLife, Inc. (NYSE:MET - Free Report) by 3.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 958,867 shares of the financial services provider's stock after acquiring an additional 33,994 shares during the period. Jacobs Levy Equity Management Inc. owned 0.14% of MetLife worth $76,987,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in MET. Brighton Jones LLC grew its holdings in MetLife by 9.0% in the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after acquiring an additional 351 shares during the last quarter. Benjamin Edwards Inc. raised its holdings in MetLife by 37.5% in the fourth quarter. Benjamin Edwards Inc. now owns 21,875 shares of the financial services provider's stock worth $1,791,000 after buying an additional 5,965 shares during the last quarter. Captrust Financial Advisors raised its holdings in MetLife by 12.9% in the fourth quarter. Captrust Financial Advisors now owns 50,229 shares of the financial services provider's stock worth $4,113,000 after buying an additional 5,729 shares during the last quarter. Cetera Investment Advisers raised its holdings in MetLife by 2.2% in the fourth quarter. Cetera Investment Advisers now owns 189,333 shares of the financial services provider's stock worth $15,503,000 after buying an additional 4,149 shares during the last quarter. Finally, Concentric Capital Strategies LP purchased a new position in shares of MetLife during the fourth quarter valued at approximately $1,693,000. Institutional investors own 94.99% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of MetLife from $98.00 to $94.00 and set an "overweight" rating for the company in a report on Monday, August 18th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, August 11th. UBS Group cut their target price on shares of MetLife from $94.00 to $91.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Barclays boosted their target price on shares of MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Finally, Cowen restated a "buy" rating on shares of MetLife in a research report on Friday, August 22nd. Ten analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $95.60.

Read Our Latest Report on MET

MetLife Price Performance

Shares of MET stock traded down $0.28 on Tuesday, hitting $79.32. 2,421,678 shares of the stock traded hands, compared to its average volume of 3,369,593. The firm has a market cap of $52.75 billion, a price-to-earnings ratio of 13.44, a PEG ratio of 0.71 and a beta of 0.87. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The firm has a 50 day simple moving average of $78.25 and a two-hundred day simple moving average of $78.32. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). The firm had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm's revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.28 earnings per share. As a group, equities research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th will be paid a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife's dividend payout ratio is currently 38.47%.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.